News
Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Optieum Biotechnologies, Inc. (Optieum), a preclinical stage company dedicated to the discovery and ...
Choose from Pharma Logo stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Plans and pricing Video Back Videos home Signature collection ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
Choose from Pharmaceutical Logo stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...
Matica Biotechnology, a specialized contract development and manufacturing organization (CDMO) for cell and gene therapies (CGT), has entered into a strategic partnership with the National Center for ...
Enrolled first patients in first 4D-150 Phase 3 clinical trial (4FRONT-1) in wet AMD, with over 50 clinical trial sites open to date Initiation of second 4D-150 Phase 3 clinical trial (4FRONT-2) ...
Detailed price information for Krystal Biotech Inc (KRYS-Q) from The Globe and Mail including charting and trades.
Enrolled first patients in first 4D-150 Phase 3 clinical trial (4FRONT-1) in wet AMD, with over 50 clinical trial sites open to dateInitiation of second 4D-150 Phase 3 clinical trial (4FRONT-2) expect ...
Rock band Alice in Chains has canceled its forthcoming shows and festival appearances to prioritize the health of drummer ...
2don MSN
Josh Charles is set to play the lead in Best Medicine, a Fox series remake of the hit UK medical comedy-drama Doc Martin.
13d
News-Medical.Net on MSNScientists say global conditions are ripe for a yellow fever pandemicA new study in npj Viruses warns that global trends like urbanization, travel, and mosquito spread are amplifying the risk of ...
HB 57 also includes two provisions that will improve learning opportunities and outcomes. The first provides per-pupil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results